New Issue: ABN Amro sells $4.9 million of 9% reverse exchangeables linked to Merck

By Jennifer Chiou

New York, June 23 - ABN Amro Bank NV priced $4.9 million of one-year 9% reverse exchangeable notes linked to Merck & Co., Inc. common stock, according to a 424B3 filing with the Securities and Exchange Commission.

Issuer:	ABN Amro Bank NV
Issue:	Reverse exchangeable senior medium-term series A notes
Underlying stock:	Merck & Co., Inc.
Amount:	$4.9 million
Maturity:	June 22, 2006
Coupon:	9.00%
Price:	Par
Payout at maturity:	If Merck stock finishes below initial price of $32.22, 31.037 Merck shares per $1,000 principal amount or par in cash
Initial price:	$32.22 (closing price of Merck stock on pricing date)
Exchange ratio:	31.037
Call:	Non-callable
Pricing date:	June 17
Settlement date:	June 22
Lead manager:	ABN Amro Financial Services, Inc.
Distribution:	Off shelf

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.